Targeting NFE2L2/GPX4 signaling pathway: Therapeutic potential of arsenic sulfide-induced ferroptosis in combating rhabdomyosarcoma
• Arsenic sulfide suppressed RMS cell growth. • Arsenic sulfide induced ferroptosis in RMS cells. • Arsenic sulfide induced ferroptosis via NFE2L2/GPX4 signaling pathway in RMS cells.
Authors
- Yawei Zhao (ORCID: https://orcid.org/0000-0002-1689-5406)
- Ruizhe Huang (ORCID: https://orcid.org/0000-0001-8494-9077)
- Yu Cai (ORCID: https://orcid.org/0000-0001-8804-2616)
- Siyu Chen (ORCID: https://orcid.org/0000-0002-7549-5840)
- Zhiyi Liu (ORCID: https://orcid.org/0000-0002-8122-8474)
- Shumin Lu
- Chuanying Zhu (ORCID: https://orcid.org/0000-0002-1958-8401)
- Ting Kang (ORCID: https://orcid.org/0000-0001-6255-2378)
Institutions
- XinHua Hospital (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.intimp.2024.113614
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China